Valamehr Bahram

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
17
Insider Sells Sum
$17.04M

Insider Activity of Valamehr Bahram

According to the SEC Form 4 filings, Valamehr Bahram, being in a position of

  1. Chief R&D Officer at Fate Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11271 share for $49,367,
    over all time since 2019-10-15, has bought 0 shares, and sold 293598 shares for $17.04M.

The largest sale of all time was on 2020-12-14 and amounted to 50000 shares of Fate Therapeutics, Inc. for $4.89M.

Biography of Valamehr Bahram

No biography is available at this moment.

2024-01-09SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
11,271
0.0114%
$4.38$49,367-11.33%
2023-01-10SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
10,917
0.0106%
$5.24$57,205-13.57%
2022-07-07SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
17,158
0.0173%
$30.23$518,686-68.12%
2022-07-06SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
7,842
0.0085%
$30.07$235,809-65.07%
2022-03-14SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
2,960
0.0034%
$33.30$98,568-24.5%
2022-01-11SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
4,570
0.0048%
$48.50$221,655-43.63%
2022-01-10SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
5,596
0.0055%
$46.38$259,558-45.37%
2021-12-13SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
25,000
0.0257%
$47.66$1.19M-39.14%
2021-09-13SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
25,000
0.0264%
$66.29$1.66M-44.34%
2021-06-14SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
25,000
0.0263%
$89.32$2.23M-40.2%
2021-03-15SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
25,000
0.0266%
$92.35$2.31M-26.56%
2021-01-11SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
3,254
0.0034%
$110.81$360,588-31.03%
2021-01-08SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
6,230
0.0067%
$117.10$729,552-33.06%
2020-12-14SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
50,000
0.0581%
$97.78$4.89M-15.66%
2020-09-14SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
50,000
0.0558%
$36.31$1.82M+120.49%
2020-01-08SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
11,400
0.0141%
$20.69$235,895+51.02%
2019-10-15SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
12,400
0.0158%
$14.18$175,781+95.66%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.